Literature DB >> 31180070

The indirect costs of allergic diseases.

Joanna Stróżek1, Bolesław Krzysztof Samoliński2, Anna Kłak3, Emilia Gawińska-Drużba4, Radosław Izdebski5, Edyta Krzych-Fałta6, Filip Raciborski7.   

Abstract

It is estimated that every third person living in Europe suffers from allergic diseases. Allergies are a growing health problem in Poland where 40% of the population have allergy symptoms, including 12% afflicted with asthma. The actual cost of allergic diseases is difficult to estimate due to the lack or incompleteness of the relevant data. The aim of this review is to present estimates of the indirect costs of allergic diseases in Poland and globally, using asthma, allergic rhinitis and atopic dermatitis as examples. The analysis also includes the impact of allergic diseases on the costs to the social welfare system and employers. The literature review of the indirect costs of allergic diseases shows that the indirect costs of a disease, which substantially exceed the direct costs, increase with the disease activity and severity. Interestingly, some studies have found that the indirect costs of lost productivity due to hours missed from work to take care of a sick child could be threefold higher than those of absence due to a worker's own illness. The indirect costs of a disease can be significantly reduced by early diagnosis and appropriate treatment. Int J Occup Med Environ Health. 2019;32(3):281-90. This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Entities:  

Keywords:  Europe; allergic rhinitis; allergy; asthma; atopic dermatitis; indirect costs

Mesh:

Year:  2019        PMID: 31180070     DOI: 10.13075/ijomeh.1896.01275

Source DB:  PubMed          Journal:  Int J Occup Med Environ Health        ISSN: 1232-1087            Impact factor:   1.843


  5 in total

1.  Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity.

Authors:  Jessica Keim-Malpass; H Charles Malpass
Journal:  Clinicoecon Outcomes Res       Date:  2022-06-17

2.  Analysis of the Serum Profile of Cytokines Involved in the T-Helper Cell Type 17 Immune Response Pathway in Atopic Children with Food Allergy.

Authors:  Kacper Packi; Joanna Matysiak; Sylwia Klimczak; Eliza Matuszewska; Anna Bręborowicz; Dagmara Pietkiewicz; Jan Matysiak
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

3.  The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support.

Authors:  Delphine Staumont-Sallé; Charles Taieb; Stephanie Merhand; Jason Shourick
Journal:  Acta Derm Venereol       Date:  2021-12-13       Impact factor: 3.875

4.  Lifelong Impact of Severe Atopic Dermatitis on Quality of Life: A Case Report.

Authors:  Arjun M Bashyam; Sohini Ganguli; Puneet Mahajan; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-09

Review 5.  The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases.

Authors:  Haocheng Zheng; Yi Zhang; Jiachuang Pan; Nannan Liu; Yu Qin; Linghui Qiu; Min Liu; Tieshan Wang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.